Funding for the provision of Recombinant Factor VIII for each strategic health authority (SHA) is in the SHA bundle, that incorporates a number of budgets formerly managed directly by the Department. The value of the SHA bundle for 2007-08 is £6,945.78 million, and was announced in the NHS Operating Framework that was published on 11 December to the NHS. Allocations are made direct to SHAs, and they manage the distribution of funds among the different programmes, including for Recombinant Factor VIII, taking account of local circumstances.